New analysis shows high-dose, once-daily Enerzair Breezhaler cut asthma exacerbation rates by 21% (moderate or severe) and 31% […]

The personalised cancer treatment has received conditional approval in the US

Updated Date: Fri, 28 Aug 2020 00:00:00 EDT

Updated Date: Fri, 28 Aug 2020 00:00:00 EDT

Updated Date: Fri, 28 Aug 2020 00:00:00 EDT

Updated Date: Fri, 28 Aug 2020 00:00:00 EDT

Updated Date: Fri, 28 Aug 2020 00:00:00 EDT

Akebia crashes on vadadustat flop in larger anemia indication. Will AZ, FibroGen own the market? aliu Fri, 09/04/2020 […]

FiercePharmaAsia—Biocon, Mylan’s Lantus copy; Samsung rides COVID demand; Adlai Nortye’s C round aliu Fri, 09/04/2020 – 06:28

With new AveXis name, Novartis spotlights marquee role for gene therapy business bbulik Fri, 09/04/2020 – 09:19